Retrieved from Clinical Drig Investigation: Baldwin, G., Compton, W
Beyond the clinical criteria, semaglutide tends to be the strongest fit for patients who have struggled with persistent hunger and food cravings as the primary driver of their weight challenges, patients with insulin resistance or blood sugar dysregulation, and patients looking for a once-weekly protocol that does not require daily medication management
Sue Stockden, a patient living in the West Midlands who currently takes privately prescribed Mounjaro, told The Pharmaceutical Journal that she knew of patients ordering up to seven or eight pens at a time by accessing them through multiple providers, often using credit cards to spend more than 1,000 to do so
Neuro Endocrinol Lett
The GLP-90 program: Willow newer offering Willow has introduced a program called GLP-90, priced at $399 per month for three months